List of Tables
Table 1. Insomnia Medication Market Trends
Table 2. Insomnia Medication Market Drivers & Opportunity
Table 3. Insomnia Medication Market Challenges
Table 4. Insomnia Medication Market Restraints
Table 5. Global Insomnia Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Insomnia Medication Revenue Market Share by Company (2019-2024)
Table 7. Global Insomnia Medication Sales Volume by Company (2019-2024) & (K Pcs)
Table 8. Global Insomnia Medication Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Insomnia Medication Price by Company (2019-2024) & (USD/Pcs)
Table 10. Key Manufacturers Insomnia Medication Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Insomnia Medication Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Insomnia Medication
Table 13. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Insomnia Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Insomnia Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Insomnia Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Insomnia Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Insomnia Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Insomnia Medication Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
Table 22. Global Insomnia Medication Sales Volume by Type (2019-2024) & (K Pcs)
Table 23. Global Insomnia Medication Sales Volume by Type (2025-2030) & (K Pcs)
Table 24. Global Insomnia Medication Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Insomnia Medication Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Insomnia Medication Price by Type (2019-2024) & (USD/Pcs)
Table 27. Global Insomnia Medication Price by Type (2025-2030) & (USD/Pcs)
Table 28. Global Insomnia Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Insomnia Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Insomnia Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Insomnia Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Insomnia Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Insomnia Medication Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
Table 34. Global Insomnia Medication Sales Volume by Application (2019-2024) & (K Pcs)
Table 35. Global Insomnia Medication Sales Volume by Application (2025-2030) & (K Pcs)
Table 36. Global Insomnia Medication Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Insomnia Medication Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Insomnia Medication Price by Application (2019-2024) & (USD/Pcs)
Table 39. Global Insomnia Medication Price by Application (2025-2030) & (USD/Pcs)
Table 40. Global Insomnia Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Insomnia Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Insomnia Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Insomnia Medication Sales Value by Region (2019-2024) & (%)
Table 44. Global Insomnia Medication Sales Value by Region (2025-2030) & (%)
Table 45. Global Insomnia Medication Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
Table 46. Global Insomnia Medication Sales Volume by Region (2019-2024) & (K Pcs)
Table 47. Global Insomnia Medication Sales Volume by Region (2025-2030) & (K Pcs)
Table 48. Global Insomnia Medication Sales Volume by Region (2019-2024) & (%)
Table 49. Global Insomnia Medication Sales Volume by Region (2025-2030) & (%)
Table 50. Global Insomnia Medication Average Price by Region (2019-2024) & (USD/Pcs)
Table 51. Global Insomnia Medication Average Price by Region (2025-2030) & (USD/Pcs)
Table 52. Key Countries/Regions Insomnia Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Insomnia Medication Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Insomnia Medication Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Insomnia Medication Sales Volume, (2019-2024) & (K Pcs)
Table 56. Key Countries/Regions Insomnia Medication Sales Volume, (2025-2030) & (K Pcs)
Table 57. Eisai Company Information
Table 58. Eisai Introduction and Business Overview
Table 59. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 60. Eisai Insomnia Medication Product Offerings
Table 61. Eisai Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 65. Merck Insomnia Medication Product Offerings
Table 66. Merck Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 70. Pfizer Insomnia Medication Product Offerings
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 75. Sanofi Insomnia Medication Product Offerings
Table 76. Sanofi Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Introduction and Business Overview
Table 79. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 80. Takeda Insomnia Medication Product Offerings
Table 81. Takeda Recent Development
Table 82. Vanda Pharmaceuticals Company Information
Table 83. Vanda Pharmaceuticals Introduction and Business Overview
Table 84. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Vanda Pharmaceuticals Insomnia Medication Product Offerings
Table 86. Vanda Pharmaceuticals Recent Development
Table 87. Astellas Company Information
Table 88. Astellas Introduction and Business Overview
Table 89. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. Astellas Insomnia Medication Product Offerings
Table 91. Astellas Recent Development
Table 92. Dainippon Sumitomo Company Information
Table 93. Dainippon Sumitomo Introduction and Business Overview
Table 94. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. Dainippon Sumitomo Insomnia Medication Product Offerings
Table 96. Dainippon Sumitomo Recent Development
Table 97. ECR Pharmaceuticals (Valeant) Company Information
Table 98. ECR Pharmaceuticals (Valeant) Introduction and Business Overview
Table 99. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
Table 101. ECR Pharmaceuticals (Valeant) Recent Development
Table 102. Flynn Pharma Company Information
Table 103. Flynn Pharma Introduction and Business Overview
Table 104. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Flynn Pharma Insomnia Medication Product Offerings
Table 106. Flynn Pharma Recent Development
Table 107. Johnson & Johnson Company Information
Table 108. Johnson & Johnson Introduction and Business Overview
Table 109. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Insomnia Medication Product Offerings
Table 111. Johnson & Johnson Recent Development
Table 112. Meda Company Information
Table 113. Meda Introduction and Business Overview
Table 114. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 115. Meda Insomnia Medication Product Offerings
Table 116. Meda Recent Development
Table 117. Somnus Therapeutics Company Information
Table 118. Somnus Therapeutics Introduction and Business Overview
Table 119. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 120. Somnus Therapeutics Insomnia Medication Product Offerings
Table 121. Somnus Therapeutics Recent Development
Table 122. Purdue Pharma Company Information
Table 123. Purdue Pharma Introduction and Business Overview
Table 124. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 125. Purdue Pharma Insomnia Medication Product Offerings
Table 126. Purdue Pharma Recent Development
Table 127. Neurim Company Information
Table 128. Neurim Introduction and Business Overview
Table 129. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 130. Neurim Insomnia Medication Product Offerings
Table 131. Neurim Recent Development
Table 132. Minerva Neurosciences Company Information
Table 133. Minerva Neurosciences Introduction and Business Overview
Table 134. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Minerva Neurosciences Insomnia Medication Product Offerings
Table 136. Minerva Neurosciences Recent Development
Table 137. Pernix Therapeutics Company Information
Table 138. Pernix Therapeutics Introduction and Business Overview
Table 139. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 140. Pernix Therapeutics Insomnia Medication Product Offerings
Table 141. Pernix Therapeutics Recent Development
Table 142. SkyePharma Company Information
Table 143. SkyePharma Introduction and Business Overview
Table 144. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 145. SkyePharma Insomnia Medication Product Offerings
Table 146. SkyePharma Recent Development
Table 147. Paratek Pharmaceuticals Company Information
Table 148. Paratek Pharmaceuticals Introduction and Business Overview
Table 149. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 150. Paratek Pharmaceuticals Insomnia Medication Product Offerings
Table 151. Paratek Pharmaceuticals Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Insomnia Medication Downstream Customers
Table 155. Insomnia Medication Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Insomnia Medication Sales Volume (2019-2030) & (K Pcs)
Figure 5. Global Insomnia Medication Sales Price (2019-2030) & (USD/Pcs)
Figure 6. Insomnia Medication Report Years Considered
Figure 7. Global Insomnia Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Insomnia Medication Players Sales Volume Ranking (2023) & (K Pcs)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Revenue in 2023
Figure 10. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Nonbenzodiazepine Receptor Agonists Picture
Figure 12. Benzodiazepine Receptor Agonists Picture
Figure 13. The Selective Melatonin Receptor Agonist Ramelteon Picture
Figure 14. Sedating Antidepressants Picture
Figure 15. Global Insomnia Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Insomnia Medication Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Insomnia Medication Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
Figure 18. Global Insomnia Medication Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Insomnia Medication Price by Type (2019-2030) & (USD/Pcs)
Figure 20. Product Picture of Adults
Figure 21. Product Picture of Kids
Figure 22. Global Insomnia Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Insomnia Medication Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Insomnia Medication Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
Figure 25. Global Insomnia Medication Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Insomnia Medication Price by Application (2019-2030) & (USD/Pcs)
Figure 27. North America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Insomnia Medication Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Insomnia Medication Sales Volume (%), (2019-2030)
Figure 39. United States Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 45. China Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 47. China Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 57. India Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 59. India Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 60. Insomnia Medication Industrial Chain
Figure 61. Insomnia Medication Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
